Cutaneous T-cell lymphoma (CTCL) is a group of rare blood cancers that affects the largest organ in your body — your skin. CTCLs can look and feel like common skin conditions like psoriasis, eczema or even allergic reactions. Cutaneous T-cell lymphoma (CTCL) is the most common type of primary cutaneous lymphoma.

Context Explanation

It is a form of non-Hodgkin lymphoma in which malignant T-cells are initially localised to the skin with no evidence of extracutaneous disease at the time of diagnosis. CTCL stands for cutaneous T-cell lymphoma, a rare cancer of T-lymphocytes (a type of white blood cells) that involves the skin. There are several types of CTCL, but mycosis fungoides and Sézary syndrome are the most common. An overview of staging and treatment options for cutaneous T-cell lymphoma (CTCL).

Insight Material

Cutaneous T-cell Lymphomas (CTCL) - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the Merck Manuals - Medical Professional Version. Novel approaches to the diagnosis and treatment of cutaneous T cell lymphoma (CTCL). ascopubs.org: LBH589, a novel histone deacetylase inhibitor (HDACi), treatment of patients with cutaneous T-cell lymphoma (CTCL). Changes in skin gene expression profiles related to clinical ... Vorinostat (suberoylanilide hydroxamic acid, SAHA) is clinically active in advanced cutaneous T-cell lymphoma (CTCL): Results of a phase IIb trial This is an ASCO Meeting Abstract from the 2006 ASCO ...

Final Conclusion